6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-bromo-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;tert-butyl N-[[5-(8-carbamoyl-6,7-dihydro-5H-1,8-naphthyridin-3-yl)-3-pyridinyl]methyl]carbamate;tert-butyl N-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl]carbamate
C61H79BBrN15O9 — CID 158826073
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-bromo-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;tert-butyl N-[[5-(8-carbamoyl-6,7-dihydro-5H-1,8-naphthyridin-3-yl)-3-pyridinyl]methyl]carbamate;tert-butyl N-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl]carbamate
6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-bromo-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;tert-butyl N-[[5-(8-carbamoyl-6,7-dihydro-5H-1,8-naphthyridin-3-yl)-3-pyridinyl]methyl]carbamate;tert-butyl N-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl]carbamate (PubChem CID 158826073) has the molecular formula C61H79BBrN15O9 and a molecular weight of 1257.11 g/mol. Its IUPAC name is 6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-bromo-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;tert-butyl N-[[5-(8-carbamoyl-6,7-dihydro-5H-1,8-naphthyridin-3-yl)-3-pyridinyl]methyl]carbamate;tert-butyl N-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl]carbamate.
Molecular Properties
| Compound Name | 6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-bromo-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;tert-butyl N-[[5-(8-carbamoyl-6,7-dihydro-5H-1,8-naphthyridin-3-yl)-3-pyridinyl]methyl]carbamate;tert-butyl N-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl]carbamate |
|---|---|
| PubChem CID | 158826073 |
| Molecular Formula | C61H79BBrN15O9 |
| Molecular Weight | 1257.11 g/mol |
| Exact Mass | 1255.55 |
| IUPAC Name | 6-[5-(aminomethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-bromo-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;tert-butyl N-[[5-(8-carbamoyl-6,7-dihydro-5H-1,8-naphthyridin-3-yl)-3-pyridinyl]methyl]carbamate;tert-butyl N-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl]carbamate |
| SMILES | CC(C)(C)OC(=O)NCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1.CC(C)(C)OC(=O)NCc1cncc(B2OC(C)(C)C(C)(C)O2)c1.NC(=O)N1CCCc2cc(Br)cnc21.NCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1 |
| InChI | InChI=1S/C20H25N5O3.C17H27BN2O4.C15H17N5O.C9H10BrN3O/c1-20(2,3)28-19(27)24-10-13-7-15(11-22-9-13)16-8-14-5-4-6-25(18(21)26)17(14)23-12-16;1-15(2,3)22-14(21)20-10-12-8-13(11-19-9-12)18-23-16(4,5)17(6,7)24-18;16-6-10-4-12(8-18-7-10)13-5-11-2-1-3-20(15(17)21)14(11)19-9-13;10-7-4-6-2-1-3-13(9(11)14)8(6)12-5-7/h7-9,11-12H,4-6,10H2,1-3H3,(H2,21,26)(H,24,27);8-9,11H,10H2,1-7H3,(H,20,21);4-5,7-9H,1-3,6,16H2,(H2,17,21);4-5H,1-3H2,(H2,11,14) |
| InChIKey | IWLWZFRZONAORY-UHFFFAOYSA-N |
| XLogP | 8.51 |
| TPSA | 337.47 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 87 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1257.11 |
| LogP ≤ 5 | 8.51 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158826073 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.